Bigul

Granules India buyback offer opens on Sept 27

Co plans to buyback 62.5 lakh shares at 400/share
16-09-2022

GRANULES INDIA LTD.-$ - 532482 - Letter Of Offer For Buyback Of Equity Shares Of Granules India Limited

Letter of Offer for buyback of equity shares of Granules India Limited
16-09-2022

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of the Analyst/Investor Meeting
14-09-2022

GRANULES INDIA LTD.-$ - 532482 - Clarification On News Item

Clarification on news item
10-09-2022

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of the Analyst/Investor Meeting
05-09-2022

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules India Limited received ANDA approval for Loperamide Hydrochloride and Simethicone Tablets
30-08-2022

Granules gets USFDA nod for drug

Granules India now has a total of 51 ANDA approvals from the US FDA
26-08-2022

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules India Limited Received ANDA Approval for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets
26-08-2022

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules India Limited Received ANDA Approval for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets
26-08-2022

GRANULES INDIA LTD.-$ - 532482 - Update On GPI Facility

Update on GPI facility
26-08-2022